PINC 📈 Premier - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74051N1028
PINC: Medical Supplies, Pharmaceuticals, Laboratory Equipment, Food Products
Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services for coordinate purchasing decisions, review utilization and achieve and maintain standardization across member's facilities; SaaS informatics products for the purchase additional elements; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina. Web URL: https://www.premierinc.com
Additional Sources for PINC Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PINC Stock Overview
Market Cap in USD | 2,206m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2013-09-26 |
PINC Stock Ratings
Growth 5y | -49.7% |
Fundamental | 31.4% |
Dividend | 71.1% |
Rel. Strength Industry | -120 |
Analysts | 2.89/5 |
Fair Price Momentum | 21.07 USD |
Fair Price DCF | 55.10 USD |
PINC Dividends
Dividend Yield 12m | 3.86% |
Yield on Cost 5y | 2.47% |
Annual Growth 5y | 21.93% |
Payout Consistency | 100.0% |
PINC Growth Ratios
Growth Correlation 3m | 70.5% |
Growth Correlation 12m | -7.3% |
Growth Correlation 5y | -55.2% |
CAGR 5y | -8.50% |
CAGR/Mean DD 5y | -0.38 |
Sharpe Ratio 12m | -0.06 |
Alpha | -14.22 |
Beta | 0.44 |
Volatility | 21.90% |
Current Volume | 5538.8k |
Average Volume 20d | 1035.3k |
What is the price of PINC stocks?
As of December 22, 2024, the stock is trading at USD 21.76 with a total of 5,538,848 shares traded.
Over the past week, the price has changed by -0.88%, over one month by -2.65%, over three months by +6.68% and over the past year by -0.46%.
As of December 22, 2024, the stock is trading at USD 21.76 with a total of 5,538,848 shares traded.
Over the past week, the price has changed by -0.88%, over one month by -2.65%, over three months by +6.68% and over the past year by -0.46%.
Is Premier a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Premier is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PINC as of December 2024 is 21.07. This means that PINC is currently overvalued and has a potential downside of -3.17%.
Neither. Based on ValueRay Fundamental Analyses, Premier is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PINC as of December 2024 is 21.07. This means that PINC is currently overvalued and has a potential downside of -3.17%.
Is PINC a buy, sell or hold?
Premier has received a consensus analysts rating of 2.89. Therefor, it is recommend to hold PINC.
Premier has received a consensus analysts rating of 2.89. Therefor, it is recommend to hold PINC.
- Strong Buy: 0
- Buy: 0
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecast for PINC stock price target?
According to ValueRays Forecast Model, PINC Premier will be worth about 23 in December 2025. The stock is currently trading at 21.76. This means that the stock has a potential upside of +5.61%.
According to ValueRays Forecast Model, PINC Premier will be worth about 23 in December 2025. The stock is currently trading at 21.76. This means that the stock has a potential upside of +5.61%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 21.3 | -2.3% |
Analysts Target Price | 26.7 | 22.7% |
ValueRay Target Price | 23 | 5.6% |